Eloquest Healthcare, Inc. is a wholly owned subsidiary of Ferndale Pharma Group, Inc. that is focused specifically on serving hospitals, their healthcare practitioners, and patients. Eloquest Healthcare helps deliver safer, more compassionate care by providing intuitive, cost-effective solutions that aid in the prevention of hospital acquired infections.
march, 2023
3 Questions with Michelle (Mickey) Hawes, RN, DNP, CRNI, VA-BC, ACRP-CP Our “3 Questions with…” vlog series features some of the finest thought leaders in healthcare specialties such as Infection Prevention, Vascular Access, and more. These experts answer questions on the latest insights, evidence and current practices. For our newest “3 Questions With…” vlog, Eloquest…
3 Questions with Casey Schuller, BSN, RN, VA-BC Our “3 Questions with…” vlog series features some of the finest thought leaders in healthcare specialties such as Infection Prevention, Vascular Access, and more. These experts answer questions on the latest insights, evidence and current practices. For our newest “3 Questions With…” vlog, Eloquest Healthcare is proud…
The 8th edition of The Infusion Nurses Society Infusion Therapy Standards of Practice (INS Standards) makes evidence-based practice recommendations to assist health care facilities in the standardization of their vascular access device and IV therapy practices. The INS Standards indicate that insertion site selection should be determined based on the prescribed infusion therapy plan while prioritizing vessel…
3 Questions with Angelique Gaston, RN, VA-BC Our “3 Questions with…” vlog series features some of the finest thought leaders in healthcare specialties such as Infection Prevention, Vascular Access, and more. These experts answer questions on the latest insights, evidence and current practices. For our newest “3 Questions With…” vlog, Eloquest Healthcare is proud to…
Vascular Access: Target Acquired. Anchored in Position. Mission Accomplished. An overarching goal of Vascular Access Specialists is to expertly provide a patient with a reliable vascular access device that will last until the end of need; for the ‘life of the line’. In her Vascular Access Talk at the 2022 AVA Scientific Meeting titled “Target…
How to Perform an LVAD Driveline Dressing Change The following steps summarize how to perform a left ventricular assist device (LVAD) driveline dressing change with use of Mastisol® Liquid Adhesive and Detachol® Adhesive Remover, as demonstrated by Abigail Vowels, RN, BSN. Vowels is the Circulatory Device Program Leader at Dignity Health/Mercy General Hospital. In this…
As 2022 ends, we would like to thank you for reading the Eloquest Healthcare Blog! We hope you have found our posts during the last 12 months to be both informative and impactful to your professional career. Here are some of the past year’s highlights that we invite you to visit… One of our favorite…
A “STICKY” Situation: Randomized Controlled Trial Investigates Use of Liquid Adhesive to Increase Dressing Adherence & Reduce CVAD FailureCVADs – Essential Devices with High Failure Rates Central venous access devices (CVADs) are essential to the timely and effective treatment of critically ill patients. They deliver lifesaving drugs, nutrition, and blood products. Yet despite their importance,…
A Decade of Security – New Study Adds Much Needed Data Comparing CVAD Securement MethodsImportance of PICC Securement Patients who require central venous access devices (CVAD) to monitor laboratory values and receive cancer treatments, blood transfusions or other drugs may receive a peripherally inserted central catheter (PICC). Best practices have been established for proper PICC…
3 Questions with Mary Smith, RN, VA-BC, President, CVC Healthcare, LLC Our “3 Questions with…” vlog series features some of the finest thought leaders in healthcare specialties such as Infection Prevention, Vascular Access, and more. These experts answer questions on the latest insights, evidence and current practices. For our newest “3 Questions With…” vlog, Eloquest…
